Abstract:AIM: To investigate the expression of myofibrillogenesis regulator-1 (MR-1) in relation to clinicopathological parameters and postoperative survival in a group of Chinese patients with gastric cancer.METHODS: In our previous study of human whole-genome gene expression profiling, the differentially expressed genes were detected in the gastric cancer and its adjacent noncancerous mucosa. We found that MR-1 was associated with the location and differentiation of tumors. In this study, MR-1 protein expression was determined by immunohistochemistry in specimens of primary cancer and the adjacent noncancerous tissues from gastric cancer patients. A set of real-time quantitative polymerase chain reaction assays based on the Universal ProbeLibrary-a collection of 165 presynthesized, fluorescence-labeled locked nucleic acid hydrolysis probes-was designed specifically to detect the expression of MR-1 mRNA. The correlation was analyzed between the expression of MR-1 and other tumor characteristics which may influence the prognosis of gastric cancer patients. A retrospective cohort study on the prognosis was carried out and clinical data were collected from medical records.RESULTS: MR-1 mRNA and protein could be detected in gastric cancer tissues as well as in matched noncancerous tissues. MR-1 was up-regulated at both mRNA (5.459 +/- 0.639 vs 1.233 +/- 0.238, P < 0.001) and protein levels (34.2% vs 13.2%, P = 0.003) in gastric cancer tissues. Correlation analysis demonstrated that high expression of MR-1 in gastric cancer was significantly correlated with clinical stage (P = 0.034). Kaplan-Meier analysis showed that the postoperative survival of the MR-1 positive group tended to be poorer than that of the MR-1 negative group, and the difference was statistically significant (P = 0.002). Among all the patients with stage I-IV carcinoma, the 5-year survival rates of MR-1 positive and negative groups were 50.40% and 12.70%, respectively, with respective median survival times of 64.27 mo (95%CI: 13.41-115.13) and 16.77 mo (95%CI: 8.80-24.74). Univariate and multivariate analyses were performed to compare the impact of MR-1 expression and other clinicopathological parameters on prognosis. In a univariate analysis on all 70 specimens, 6 factors were found to be significantly associated with the overall survival statistically: including MR-1 expression, depth of invasion, distant metastasis, lymph node metastasis, vascular invasion and the tumor node metastasis (TNM) stage based on the 7th edition of the International Union against Cancer TNM classification. To avoid the influence caused by univariate analysis, the expressions of MR-1 as well as other parameters were examined in multivariate Cox analysis. Clinicopathological variables that might affect the prognosis of gastric cancer patients were analyzed by Cox regression analysis, which showed that MR-1 expression and TNM stage were independent predictors of postoperative survival. The best mathematical multivariate Cox regression model consisted of two factors: MR-1 expression and TNM stage. Our results indicated that MR-1 protein could act as an independent marker for patient overall survival [Hazard ratio (HR): 2.215, P = 0.043].CONCLUSION: MR-1 is an important variable that can be used to evaluate the outcome, prognosis and targeted therapy of gastric cancer patients. (C) 2012 Baishideng. All rights reserved.

Elevated JMJD1A is a Novel Predictor for Prognosis and a Potential Therapeutic Target for Gastric Cancer.

Histone Demethylase JMJD2B is Required for Tumor Cell Proliferation and Survival and is Overexpressed in Gastric Cancer

MiR-375 Frequently Downregulated in Gastric Cancer Inhibits Cell Proliferation by Targeting JAK2

Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling

Histone demethylase Jumonji domain‐containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt‐related transcription factor 3

High Expression of JMJD6 Predicts Unfavorable Survival in Lung Adenocarcinoma

Jumonji Domain Containing 2A Predicts Prognosis and Regulates Cell Growth in Lung Cancer Depending on Mir-150

MDM2 is a Useful Prognostic Biomarker for Resectable Gastric Cancer

Overexpressed MAGP1 is Associated with a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer

JMJD3 Enhances Invasiveness and Migratory Capacity of Non-Small Cell Lung Cancer Cell Via Activating EMT Signaling Pathway.

Junctional Adhesion Molecule-Like Protein Promotes Tumor Progression and Metastasis via p38 Signaling Pathway in Gastric Cancer

MiRNA-491-5p Inhibits Cell Proliferation, Invasion and Migration Via Targeting JMJD2B and Serves As a Potential Biomarker in Gastric Cancer.

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

IDDF2019-ABS-0235 METTL3 As a Potential Cancer Prognostic Marker Promotes the Proliferation and Metastasis of Gastric Cancer Cells

Myofibrillogenesis Regulator-1 Overexpression is Associated with Poor Prognosis of Gastric Cancer Patients

Expression and Prognosis Analysis of JMJD5 in Human Cancers.

Expression and Prognosis Analysis of JMJD5 in Human Cancers

JMJD2B is Required for Helicobacter Pylori-Induced Gastric Carcinogenesis Via Regulating COX-2 Expression.

THUMPD3-AS1 Is Correlated with Gastric Cancer and Regulates Cell Function through miR-1252-3p and CXCL17

Prognostic Value of the Mrna Expression of Gap Junction Α Members in Patients with Gastric Cancer

Expression of Jagged 1 Predicts Postoperative Clinical Outcome of Patients with Gastric Cancer